-
Miles and Milestones: 20 Years of the New York City Marathon
November 30, 2025
… MJFF’s Board of Directors. Learn More 2009 View footage from the sidelines of the NYC Marathon course and hear from participants about why they ran for Team Fox. 2010 In … kept John Ryan strong as he trained for the NYC Marathon: “From group runs with fellow Team Fox members to the Charity …
-
News in Context: One-Patient Parkinson’s Stem Cell Trial
May 15, 2020
… of neurologists, neurosurgeons and stem cell biologists from across multiple institutions reported results of a stem … the brain of dopamine-producing cells that were derived from his own cells. Researchers used induced pluripotent … into research for one patient – in fact, teams of people from different institutions came together to complete this …
-
Targets to Therapies Initiative
… data and clarity to trigger more robust attention from drug developers. MJFF’s Targets to Therapies Initiative … targets, we continue to gather input on additional targets from experts working on them. To contribute to future target … and Selection Core — a team of representatives from biotech, pharmaceutical companies, investment firms, …
-
The Bachmann-Strauss Dystonia & Parkinson Foundation Timeline
… seek medical attention. Bonnie visits all types of doctors, from psychiatrists to chiropractors, seeking answers. In … seek medical attention. Bonnie visits all types of doctors, from psychiatrists to chiropractors, seeking answers. In … gene, DYT-1, identified Partially supported by a grant from Bachmann-Strauss, a team led by Xandra Breakefield, …
-
Application Guidelines
… inclusion: The Foundation strongly encourages applications from a wide and diverse range of investigators, including … reasonable care in protecting such Confidential Information from disclosure to third parties that do not participate in … To ensure an impartial process, a reviewer will be excluded from serving on a grant review committee (GRC) if: The …
-
Targeting Serotonin Transporters for the Treatment of L-DOPA-induced Dyskinesia
… these compounds act. Progress Report Preliminary findings from our laboratory had suggested that the FDA-approved … L-DOPA’s anti-parkinsonian efficacy. Preliminary findings from our second experiment, examining the protective effects … & Publications Peer-Reviewed Research Articles: Bishop, C., George, J.A., Buchta, W., Goldenberg, A.A., …